fluoxetine has been researched along with Acquired Immunodeficiency Syndrome in 11 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Acquired Immunodeficiency Syndrome: An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.
Excerpt | Relevance | Reference |
---|---|---|
"One hundred twenty-three men with HIV/AIDS with a Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition depressive disorder entered the 8-week trial and were randomized to testosterone (up to 400 mg IM testosterone cypionate biweekly), fluoxetine (up to 60 mg/d), or double placebo." | 9.11 | Testosterone versus fluoxetine for depression and fatigue in HIV/AIDS: a placebo-controlled trial. ( Lin, SH; McElhiney, MC; Rabkin, JG; Rabkin, R; Wagner, GJ, 2004) |
"Fluoxetine has shown superior efficacy compared with placebo in the treatment of depression in patients with HIV/AIDS, diabetes mellitus or stroke; however, it has not significantly improved depressive symptoms versus placebo in patients with cancer." | 8.81 | Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness. ( Cheer, SM; Goa, KL, 2001) |
"One hundred twenty-three men with HIV/AIDS with a Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition depressive disorder entered the 8-week trial and were randomized to testosterone (up to 400 mg IM testosterone cypionate biweekly), fluoxetine (up to 60 mg/d), or double placebo." | 5.11 | Testosterone versus fluoxetine for depression and fatigue in HIV/AIDS: a placebo-controlled trial. ( Lin, SH; McElhiney, MC; Rabkin, JG; Rabkin, R; Wagner, GJ, 2004) |
"Fluoxetine has shown superior efficacy compared with placebo in the treatment of depression in patients with HIV/AIDS, diabetes mellitus or stroke; however, it has not significantly improved depressive symptoms versus placebo in patients with cancer." | 4.81 | Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness. ( Cheer, SM; Goa, KL, 2001) |
"Fluoxetine is an effective antidepressant in the context of HIV illness." | 2.69 | Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial. ( Rabkin, JG; Rabkin, R; Wagner, GJ, 1999) |
"Of 60 AIDS patients, 32 patients had received highly active antiretroviral therapy and received subsequent assessment of lymphocyte cell counts 1 month later." | 1.33 | Lymphocyte subsets and viral load in male AIDS patients with major depression: naturalistic study. ( Huang, TL; Leu, HS; Liu, JW, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (72.73) | 18.2507 |
2000's | 3 (27.27) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rabkin, JG | 3 |
Wagner, GJ | 2 |
McElhiney, MC | 1 |
Rabkin, R | 3 |
Lin, SH | 1 |
Huang, TL | 1 |
Leu, HS | 1 |
Liu, JW | 1 |
Wagner, G | 1 |
Kraus, RP | 1 |
Nicholson, IR | 1 |
Ferrando, SJ | 1 |
Goldman, JD | 1 |
Charness, WE | 1 |
Cheer, SM | 1 |
Goa, KL | 1 |
Rosenthal, E | 1 |
Bodokh, I | 1 |
Chichmanian, RM | 1 |
Pesce, A | 1 |
Vinti, H | 1 |
Reboulot, B | 1 |
Cassuto, JP | 1 |
Fernandez, F | 1 |
Levy, JK | 1 |
Perkins, DO | 1 |
Evans, DL | 1 |
Hintz, S | 1 |
Kuck, J | 1 |
Peterkin, JJ | 1 |
Volk, DM | 1 |
Zisook, S | 1 |
2 reviews available for fluoxetine and Acquired Immunodeficiency Syndrome
Article | Year |
---|---|
Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness.
Topics: Acquired Immunodeficiency Syndrome; Antidepressive Agents; Clinical Trials as Topic; Cytochrome P-45 | 2001 |
Psychopharmacotherapy of psychiatric syndromes in asymptomatic and symptomatic HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antidepressive Agents; Anxiety Disorders; Bupropion; Depr | 1991 |
4 trials available for fluoxetine and Acquired Immunodeficiency Syndrome
Article | Year |
---|---|
Testosterone versus fluoxetine for depression and fatigue in HIV/AIDS: a placebo-controlled trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; Chi-Square Distribution; Depressive Disorder; Double-Blin | 2004 |
Effects of fluoxetine on mood and immune status in depressed patients with HIV illness.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Affect; Aged; CD4-Positive T-Lymphocytes; Dep | 1994 |
Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS. Improvements in affective and somatic symptoms.
Topics: 1-Naphthylamine; Acquired Immunodeficiency Syndrome; Adaptation, Psychological; Adult; Depressive Di | 1997 |
Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial.
Topics: Acquired Immunodeficiency Syndrome; Adult; CD4 Lymphocyte Count; Depressive Disorder; Double-Blind M | 1999 |
5 other studies available for fluoxetine and Acquired Immunodeficiency Syndrome
Article | Year |
---|---|
Lymphocyte subsets and viral load in male AIDS patients with major depression: naturalistic study.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antidepressive Agents, Second-Generation; Antiretroviral | 2006 |
AIDS-related obsessive compulsive disorder: deconditioning based on fluoxetine-induced inhibition of anxiety.
Topics: Acquired Immunodeficiency Syndrome; Adult; Combined Modality Therapy; Desensitization, Psychologic; | 1996 |
[Lyell's syndrome in 2 HIV infected patients. Sulfamides are not the only culprits].
Topics: Acquired Immunodeficiency Syndrome; Adult; Chlormezanone; Fluoxetine; HIV Infections; Humans; Male; | 1991 |
Fluoxetine treatment of depression in patients with HIV infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Depressive Disorder; Fluoxetine; HIV Infections; Humans; | 1991 |
Depression in the context of human immunodeficiency virus infection: implications for treatment.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Antidepressive Agents; Depressive D | 1990 |